Our data reveals clearly distinct gene expression profiles in these 2 groups of gliomas: those with EGFR amplification express the proliferative and mesenchymal gene set defined by Phillips et al., while 1p19q codeleted gliomas express the proneural group [5]. Here, EGFR is linked to central nervous system cancer.